webinar
Phase 1 Clinical Development Program
This webinar discusses smart processes to include in your Phase 1 clinical development program to save time and cost yet add value to your clinical asset. Cut time, not corners.
Resources to Consider
fact-sheet
From Preclinical Through Phase 1
Frontage now offering a seamless path from small molecule candidate selection through Phas...
case-study
Phase 1 Study of OMN54 – Aneustat
Frontage ran a Phase I Study of OMN54 (Aneustat™) in patients with advanced malignancies...
webinar
Strategies and Solutions for Early Phase Formulation Development and...
In this webinar, we discuss the strategies to overcome challenges during formulation devel...
poster
Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase...
Oligonucleotides (OGNs) have attracted massive attention as therapeutics due to their abil...
poster
Quantitation Of Four Chiral Drug Compounds Simultaneously Using...
Chiral separation is important but also challenging for bioanalysis of the antifungal drug...
poster
A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...
Brilaroxazine (BXZ, RP5063) is an investigational drug in development by Reviva Pharmaceut...
poster
AAIC 2025: Comparison of Plasma pTau217 Assays on Different Platforms
Plasma pTau217 was recently discovered as a prominent blood-based biomarker in the early d...
poster
Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...
Alzheimer’s disease (AD) is a neurodegenerative disorder which stands as one of the most...
poster
Identification of the Major Circulating Metabolite of Mymd-1 And...
MYMD-1 is an immunomodulator that is currently entering Phase II clinical development for ...
